Shareholder in company LXU (LXU) plans Rule 144 stock sale in 2026

Rhea-AI Filing Summary

A shareholder of the company with ticker LXU has filed a notice of proposed sale under Rule 144 to sell 19,550 common shares. The filing lists an aggregate market value of $195,304.50 for these shares, with UBS Financial Services Inc. named as broker and the sale targeted for January 14, 2026 on the NYSE. The filing also notes that 71,944,499 shares of this class were outstanding.

The shares to be sold were acquired through multiple stock awards from the issuer between 2019 and 2021, with individual awards dated March 4, 2019; January 5, 2020; December 14, 2020; and October 8, 2021. The form states that the seller represents they do not know of any undisclosed material adverse information about the issuer’s current or prospective operations, consistent with Rule 144 requirements.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services Inc. 11 Madison Avenue 4th Floor New York NY 10010	19550	195304.50	71944499	01/14/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/04/2019	Stock Award	Issuer			2091	03/04/2019	N/A
Common	10/08/2021	Stock Award	Issuer			5126	10/08/2021	N/A
Common	12/14/2020	Stock Award	Issuer			7204	12/14/2020	N/A
Common	10/08/2021	Stock Award	Issuer			2161	10/08/2021	N/A
Common	01/05/2020	Stock Award	Issuer			2518	01/05/2020	N/A
Common	10/08/2021	Stock Award	Issuer			455	10/08/2021	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does this Form 144 filing for LXU disclose?

The filing discloses that a shareholder of the company with ticker LXU intends to sell 19,550 shares of common stock under Rule 144, using UBS Financial Services Inc. as broker.

How many LXU shares are planned to be sold and what is their value?

The notice covers a proposed sale of 19,550 common shares with an aggregate market value of $195,304.50.

On which exchange and approximate date are the LXU shares expected to be sold?

The seller indicates an approximate sale date of January 14, 2026, with the shares to be sold on the NYSE.

How many LXU shares of this class are outstanding?

The form reports that 71,944,499 shares of this class of common stock were outstanding.

How were the LXU shares being sold under Rule 144 originally acquired?

The shares were acquired through several stock awards from the issuer on dates including March 4, 2019, January 5, 2020, December 14, 2020, and October 8, 2021.

What representation does the selling shareholder make in this Rule 144 notice for LXU?

The seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.